海森药业
(001367)
| 流通市值：10.34亿 | | | 总市值：40.59亿 |
| 流通股本：3870.89万 | | | 总股本：1.52亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 242,085,860.34 | 118,478,458.16 | 471,510,162.35 | 320,044,589.93 |
| 营业收入 | 242,085,860.34 | 118,478,458.16 | 471,510,162.35 | 320,044,589.93 |
| 二、营业总成本 | 172,703,186.5 | 83,568,452.19 | 333,026,439.58 | 220,992,411.05 |
| 营业成本 | 134,299,857.47 | 66,096,444.72 | 275,963,542.65 | 187,645,243.67 |
| 税金及附加 | 2,316,429.81 | 1,014,074.35 | 4,358,439.45 | 3,346,394.48 |
| 销售费用 | 6,736,212.56 | 2,561,780.56 | 12,350,194.59 | 8,665,871.18 |
| 管理费用 | 15,493,232.38 | 7,009,664.4 | 30,708,432.11 | 18,198,366.58 |
| 研发费用 | 17,710,879.4 | 9,441,180.96 | 27,779,529.02 | 17,831,319.55 |
| 财务费用 | -3,853,425.12 | -2,554,692.8 | -18,133,698.24 | -14,694,784.41 |
| 其中:利息费用 | 172,786.65 | 84,933 | 373,719.12 | 279,121.44 |
| 其中:利息收入 | 3,078,235.75 | 1,918,551.51 | 15,413,428.75 | 13,284,083 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 568,726.36 | 213,663.34 | 3,000,531.5 | 174,271.23 |
| 资产减值损失(新) | -256,904.14 | -13,758.75 | -3,537,464.09 | -592,848.05 |
| 信用减值损失(新) | -448,213.25 | 45,086.1 | -101,545.95 | 799,755.32 |
| 其他收益 | 979,474.51 | 657,757.39 | 4,200,666.71 | 2,196,462.59 |
| 四、营业利润 | 70,225,757.32 | 35,812,754.05 | 142,045,910.94 | 101,629,819.97 |
| 加:营业外收入 | 566,788.1 | 501,168.49 | 1,228,509.64 | 63,399.64 |
| 减:营业外支出 | 298,548.8 | 125,015.55 | 1,488,981.64 | 1,435,725.78 |
| 五、利润总额 | 70,493,996.62 | 36,188,906.99 | 141,785,438.94 | 100,257,493.83 |
| 减:所得税费用 | 9,699,843.31 | 4,976,725.4 | 19,227,707.29 | 13,307,355.25 |
| 六、净利润 | 60,794,153.31 | 31,212,181.59 | 122,557,731.65 | 86,950,138.58 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 60,794,153.31 | 31,212,181.59 | 122,557,731.65 | 86,950,138.58 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 60,794,153.31 | 31,212,181.59 | 122,557,731.65 | 86,950,138.58 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.41 | 0.31 | 1.22 | 0.86 |
| (二)稀释每股收益 | 0.4 | 0.3 | 1.21 | 0.86 |
| 九、综合收益总额 | 60,794,153.31 | 31,212,181.59 | 122,557,731.65 | 86,950,138.58 |
| 归属于母公司股东的综合收益总额 | 60,794,153.31 | 31,212,181.59 | 122,557,731.65 | 86,950,138.58 |
| 公告日期 | 2025-08-15 | 2025-04-26 | 2025-03-28 | 2024-10-18 |
| 审计意见(境内) | | | 标准无保留意见 | |